...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication

Exactly, the world is weird place as universe is mental.

Who could have imagined this possible turn of events!

As per RVX Newly come about potential, ABET ability to inhibit expression of ACE2, the receptor used by the virus particles to gain entery into cells is of major importance!!

The proposed ability of ABET in the recent article to also disrupt viral replications at DNA levels, in case it gets energy into cells, would be an icing on the cake!

This evolving events might prove tremendously valuable for RVX & if verified, ABET ability might be operative to combat other viral infections in the same class!!

Share
New Message
Please login to post a reply